oseltamivir has been researched along with Pulmonary Disease, Chronic Obstructive in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Q; Fei, GH; Ji, S; Shen, JL; Wang, S; Wu, X; Zhang, DW | 1 |
| Cavallazzi, R; DeLapp, DA; Furmanek, S; Glick, C; Ramirez, JA | 1 |
| Chen, Y; Chi, YM; Du, JF; Du, WX; Han, GC; Li, M; Liu, F | 1 |
| Choudhary, C; Moghekar, A; Narula, T; Raman, D; Reddy, AJ; Wiesen, J | 1 |
| Azziz-Baumgartner, E; Blanco, N; Bonilla, L; Chacon, R; Clara, WA; Guzman, G; Jara, J; Minaya, P; Mirza, S; Moreno, L; Palekar, R; Paredes, A; Rodriguez, D; Then, CJ | 1 |
| La Combe, B; Lepere, V; Messika, J; Ricard, JD | 1 |
| Campbell, SM; Green, DA; Hitoaliaj, L; Kotansky, B; Peaper, DR | 1 |
| Abed, Y; Baz, M; Boivin, G; Bouhy, X; Hamelin, ME; Papenburg, J | 1 |
| Al Aklabi, MM; Ghorpade, N; Humar, A; Weinkauf, JG | 1 |
| Carrascosa, M; Fariñas, MC; Fariñas-Álvarez, C; González-Fernández, JL; Gutiérrez-Cuadra, M; Parra, JA; Rodríguez-Cundin, P; San Juan, MV | 1 |
| Pegram, PS; Williamson, JC | 1 |
| Wesseling, G | 1 |
2 review(s) available for oseltamivir and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Neuraminidase inhibitors in patients with underlying airways disease.
Topics: Acetamides; Amantadine; Antiviral Agents; Asthma; Bronchial Spasm; Comorbidity; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive; Pyrans; Rimantadine; Risk Factors; Sialic Acids; Zanamivir | 2002 |
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment.
Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Rimantadine; Zanamivir | 2007 |
2 trial(s) available for oseltamivir and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Patients with Obesity Have Better Long-Term Outcomes after Hospitalization for COPD Exacerbation.
Topics: Aged; Antiviral Agents; Body Mass Index; Disease Progression; Female; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Obesity; Oseltamivir; Pulmonary Disease, Chronic Obstructive | 2020 |
Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial.
Topics: Antiviral Agents; Enzyme Inhibitors; Female; Humans; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Zanamivir | 2020 |
8 other study(ies) available for oseltamivir and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.
Topics: Acute Lung Injury; Animals; Antiviral Agents; Bronchi; Bronchoalveolar Lavage Fluid; Cell Line; Coculture Techniques; Drugs, Chinese Herbal; Epithelial Cells; Humans; Inflammasomes; Inflammation; Influenza A virus; Influenza, Human; Interleukin-18; Interleukin-1beta; Lung; Male; Orthomyxoviridae Infections; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Viral Load | 2020 |
A patient with acute COPD exacerbation and shock.
Topics: Acute Disease; Aged, 80 and over; Antiviral Agents; Central Venous Catheters; Critical Care; Echocardiography; Embolism, Air; Hemodynamics; Humans; Influenza A virus; Influenza, Human; Male; Oseltamivir; Point-of-Care Systems; Positive-Pressure Respiration; Pulmonary Disease, Chronic Obstructive; Respiration, Artificial; Shock; Treatment Outcome; Ventricular Dysfunction, Right | 2013 |
Demographic and clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in Central America and Dominican Republic 2009-2010.
Topics: Adolescent; Adult; Antiviral Agents; Asthma; Central America; Comorbidity; Costa Rica; Disease Outbreaks; Dominican Republic; El Salvador; Female; Fever; Guatemala; Honduras; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Nicaragua; Oseltamivir; Pregnancy; Pulmonary Disease, Chronic Obstructive; Young Adult | 2015 |
High-flow nasal cannula oxygen supply as treatment in hypercapnic respiratory failure.
Topics: Aged; Antiviral Agents; Cannula; Humans; Hypercapnia; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Noninvasive Ventilation; Oseltamivir; Oxygen Inhalation Therapy; Pneumonia, Viral; Positive-Pressure Respiration; Pulmonary Disease, Chronic Obstructive; Respiratory Insufficiency; Treatment Failure | 2016 |
Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Anti-Bacterial Agents; Asthma; Emergency Service, Hospital; Female; Humans; Influenza, Human; Male; Middle Aged; Orthomyxoviridae; Oseltamivir; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Retrospective Studies | 2016 |
Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
Topics: Adolescent; Antiviral Agents; Asthma; Chemoprevention; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Microbial Sensitivity Tests; Mutation; Neuraminidase; Oseltamivir; Pulmonary Disease, Chronic Obstructive | 2009 |
Successful bilateral lung transplantation in a patient with end-stage lung disease and positive novel influenza virus (H1N1).
Topics: Antiviral Agents; Bronchoalveolar Lavage; Humans; Incidental Findings; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung; Lung Transplantation; Male; Middle Aged; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2010 |
Clinical characteristics and outcome of patients with pandemic 2009 Influenza A(H1N1)v virus infection admitted to hospitals with different levels of health-care.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Comorbidity; Data Collection; Disease Outbreaks; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Length of Stay; Male; Middle Aged; Oseltamivir; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiration, Artificial; Risk Factors; Spain; Treatment Outcome; Young Adult | 2012 |